XANTHOGRANULOMATOUS PROSTATITIS | ||||
Journal of Bioscience and Applied Research | ||||
Volume 8, Issue 2, June 2022, Page 118-122 PDF (477.95 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/jbaar.2022.246744 | ||||
View on SCiNiTO | ||||
Authors | ||||
Farouk Hachem* ; Imad Boualaoui; Ali Mikou; Zouaidia Fouad; Ahmed Ibrahimi; Hachem Elsayegh; Yassine Nouini | ||||
Urology “A” Department, University Hospital Center of Rabat, Morocco Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco | ||||
Abstract | ||||
Xanthogranulomatous prostatitis is a rare chronic inflammatory condition and may simulate prostatic carcinoma both clinically and microscopically. Conservative treatment is recommended for xanthogranulomatous prostatitis, including the use of alpha-blockers and corticosteroids. Surgical options, such as transurethral prostatic resection or open adenomectomy, are reserved for patients who are severely symptomatic or who have failed conservative treatment. | ||||
Keywords | ||||
Xanthogranulomatous; prostatitis; alpha-blockers; adenomectomy | ||||
Statistics Article View: 162 PDF Download: 239 |
||||